153 related articles for article (PubMed ID: 3875031)
1. New drugs in gastroenterology.
Friedman G
Mt Sinai J Med; 1985 Jun; 52(6):484-9. PubMed ID: 3875031
[No Abstract] [Full Text] [Related]
2. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
Arakawa T; Kobayashi K
Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
[No Abstract] [Full Text] [Related]
3. Review of the current status of prokinetic agents in gastroenterology.
McCallum RW
Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
[No Abstract] [Full Text] [Related]
4. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
5. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
[No Abstract] [Full Text] [Related]
6. [Significance of prostaglandins and leukotrienes in gastroenterology].
Peskar BM
Internist (Berl); 1986 Oct; 27(10):637-42. PubMed ID: 3025128
[No Abstract] [Full Text] [Related]
7. [The use of histamine H2 receptor blockaders in gastroenterology].
Waldum HL; Petersen H
Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
[No Abstract] [Full Text] [Related]
8. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Soykan I; Sarosiek I; Shifflett J; Wooten GF; McCallum RW
Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic advances in the treatment of gastrointestinal diseases.
Angelides A; Fitzgerald JF
Pediatr Clin North Am; 1981 Feb; 28(1):95-112. PubMed ID: 7208141
[No Abstract] [Full Text] [Related]
10. [Prostaglandin analogs in ulcer therapy].
Hotz J
Z Gastroenterol Verh; 1991 Mar; 26():162-5. PubMed ID: 1714135
[No Abstract] [Full Text] [Related]
11. [Some problems concerning the evaluation of modern contra-ulcerous drugs. Comparison of four medicaments suppressing gastric acidity (author's transl)].
Gibinski K
Cesk Gastroenterol Vyz; 1981 May; 35(3):118-22. PubMed ID: 6269763
[No Abstract] [Full Text] [Related]
12. [Progress in the pharmacotherapy of peptic ulcer].
Stasiewicz J; Moniuszko-Jakoniuk J
Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
[No Abstract] [Full Text] [Related]
13. Role of prostaglandins in the control of gastric acid secretion.
Peskar BM
Hepatogastroenterology; 1980 Aug; 27(4):330-6. PubMed ID: 7009357
[No Abstract] [Full Text] [Related]
14. Overview of 50 years' progress in upper gastrointestinal diseases.
Yeomans ND
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S2-4. PubMed ID: 19799693
[TBL] [Abstract][Full Text] [Related]
15. [Experience in the use of losek (omeprazole) in gastroenterology].
Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
[No Abstract] [Full Text] [Related]
16. [Prostaglandin analogs for the treatment of peptic ulcer].
Mutoh H
Nihon Rinsho; 1984 Jan; 42(1):125-9. PubMed ID: 6371306
[No Abstract] [Full Text] [Related]
17. [Pathogenesis, diagnosis and therapy of ulcer disease. 11. Therapy. 7: Pharmacologic principles and therapy with prostaglandins and other substances (proglumide, psychopharmaceuticals, antiphlogistics, substances modifying motility, local anesthetics)].
Med Welt; 1984 Jan; 35(4):18-20. PubMed ID: 6700424
[No Abstract] [Full Text] [Related]
18. [Gastroesophageal reflux].
Schwizer W; Fried M
Ther Umsch; 1997 Nov; 54(11):611-6. PubMed ID: 9454361
[TBL] [Abstract][Full Text] [Related]
19. Review article: acid-related disease--what are the unmet clinical needs?
Katz PO; Scheiman JM; Barkun AN
Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
[TBL] [Abstract][Full Text] [Related]
20. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
